BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16283620)

  • 21. The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins.
    Potts PR; Yu H
    Nat Struct Mol Biol; 2007 Jul; 14(7):581-90. PubMed ID: 17589526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.
    Hu H; Zhang Y; Zou M; Yang S; Liang XQ
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1407-14. PubMed ID: 20127252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
    Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
    Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere biology in giant cell tumour of bone.
    Forsyth RG; De Boeck G; Bekaert S; De Meyer T; Taminiau AH; Uyttendaele D; Roels H; Praet MM; Hogendoorn PC
    J Pathol; 2008 Apr; 214(5):555-63. PubMed ID: 18278785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere shortening and expression of TRF1 and TRF2 in uterine leiomyoma.
    Oh BK; Choi Y; Choi JS
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells.
    Ohyashiki JH; Hayashi S; Yahata N; Iwama H; Ando K; Tauchi T; Ohyashiki K
    Int J Oncol; 2001 Mar; 18(3):593-8. PubMed ID: 11179492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the telomere complex, TERF1 and TERF2 genes in muntjac species with fusion karyotypes.
    Hartmann N; Scherthan H
    Exp Cell Res; 2005 May; 306(1):64-74. PubMed ID: 15878333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and cellular evidence for the alternative lengthening of telomeres (ALT) mechanism in chicken.
    O'Hare TH; Delany ME
    Cytogenet Genome Res; 2011; 135(1):65-78. PubMed ID: 21822009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
    Bellon M; Datta A; Brown M; Pouliquen JF; Couppie P; Kazanji M; Nicot C
    Int J Cancer; 2006 Nov; 119(9):2090-7. PubMed ID: 16786598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immortalized cells with no detectable telomerase activity. A review.
    Reddel RR; Bryan TM; Murnane JP
    Biochemistry (Mosc); 1997 Nov; 62(11):1254-62. PubMed ID: 9467849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The F-box protein β-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells.
    Wang C; Xiao H; Ma J; Zhu Y; Yu J; Sun L; Sun H; Liu Y; Jin C; Huang H
    Biochem Biophys Res Commun; 2013 May; 434(4):728-34. PubMed ID: 23583392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.
    Plantinga MJ; Pascarelli KM; Merkel AS; Lazar AJ; von Mehren M; Lev D; Broccoli D
    Mol Cancer Res; 2013 Jun; 11(6):557-67. PubMed ID: 23505069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of telomere length by the human telomeric protein TRF1.
    van Steensel B; de Lange T
    Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PinX1 is involved in telomerase recruitment and regulates telomerase function by mediating its localization.
    Cheung DH; Kung HF; Huang JJ; Shaw PC
    FEBS Lett; 2012 Sep; 586(19):3166-71. PubMed ID: 22749911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase resets the homeostatic telomere length and prevents telomere dysfunction in immortalized human cells.
    McChesney PA; Turner KC; Jackson-Cook C; Elmore LW; Holt SE
    DNA Cell Biol; 2004 May; 23(5):293-300. PubMed ID: 15199944
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions.
    Nera B; Huang HS; Lai T; Xu L
    Nat Commun; 2015 Dec; 6():10132. PubMed ID: 26640040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.